Risk factors for the first episode of klebsiella pneumoniae resistant to carbapenems infection in critically ill patients: A prospective study

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Mantzarlis, Konstantinos ^a   Makris, Demosthenes ^a   Manoulakas, Efstratios ^a   Karvouniaris, Marios ^a   Zakynthinos, Epaminondas ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; COLISTIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CRITICAL ILLNESS; DRUG EFFECT; FEMALE; GENETICS; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PATHOGENICITY; PNEUMONIA; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; CARBAPENEMS; COLISTIN; CRITICAL ILLNESS; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84893780909     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/850547     Document Type: Article

References (35)

1. Peleg A. Y., Hooper D. C., Hospital-acquired infections due to gram-negative bacteria. The New England Journal of Medicine 2010 362 19 1804 1813 2-s2.0-77952298917 10.1056/NEJMra0904124
2. Raymond D. P., Pelletier S. J., Crabtree T. D., Evans H. L., Pruett T. L., Sawyer R. G., Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients. Critical Care Medicine 2003 31 4 1035 1041 (Pubitemid 36444410)
3. Waterer G. W., Wunderink R. G., Increasing threat of Gram-negative bacteria. Critical Care Medicine 2001 29 4 supplement N75 N81 2-s2.0-0035054246 (Pubitemid 32319755)
4. Giamarellou H., Poulakou G., Multidrug-resistant gram-negative infections: what are the treatment options? Drugs 2009 69 14 1879 1901 2-s2.0-70349135927 10.2165/11315690-000000000-00000
5. Nordmann P., Cuzon G., Naas T., The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. The Lancet Infectious Diseases 2009 9 4 228 236 2-s2.0-62749195559 10.1016/S1473-3099(09)70054-4
6. Giakkoupi P., Xanthaki A., Kanelopoulo M., Vlahaki A., Miriagou V., Kontou S., Papafraggas E., Malamou-Lada H., Tzouvelekis L. S., Legakis N. J., Vatopoulos A. C., VIM-1 metallo- β -lactamase-producing Klebsiella pneumoniae strains in Greek hospitals. Journal of Clinical Microbiology 2003 41 8 3893 3896 2-s2.0-0041522306 10.1128/JCM.41.8.3893-3896.2003 (Pubitemid 36994735)
7. Leavitt A., Navon-Venezia S., Chmelnitsky I., Schwaber M. J., Carmeli Y., Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrobial Agents and Chemotherapy 2007 51 8 3026 3029 2-s2.0-34547642726 10.1128/AAC.00299-07 (Pubitemid 47206254)
8. Samra Z., Ofir O., Lishtzinsky Y., Madar-Shapiro L., Bishara J., Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. International Journal of Antimicrobial Agents 2007 30 6 525 529 2-s2.0-35948993007 10.1016/j.ijantimicag.2007.07.024 (Pubitemid 350064465)
9. Bratu S., Mooty M., Nichani S., Landman D., Gullans C., Pettinato B., Karumudi U., Tolaney P., Quale J., Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrobial Agents and Chemotherapy 2005 49 7 3018 3020 2-s2.0-21444442707 10.1128/AAC.49.7.3018-3020.2005 (Pubitemid 40917631)
10. Woodford N., Tierno P. M. Jr., Young K., Tysall L., Palepou M.-F. I., Ward E., Painter R. E., Suber D. F., Shungu D., Silver L. L., Inglima K., Kornblum J., Livermore D. M., Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β -lactamase, KPC-3, in a New York Medical Center. Antimicrobial Agents and Chemotherapy 2004 48 12 4793 4799 2-s2.0-9644265318 10.1128/AAC.48.12.4793-4799.2004 (Pubitemid 39577686)
11. Bratu S., Landman D., Haag R., Recco R., Eramo A., Alam M., Quale J., Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Archives of Internal Medicine 2005 165 12 1430 1435 2-s2.0-22144436291 10.1001/archinte.165.12.1430 (Pubitemid 40973427)
12. Gupta N., Limbago B. M., Patel J. B., Kallen A. J., Carbapenem-resistant enterobacteriaceae: epidemiology and prevention. Clinical Infectious Diseases 2011 53 1 60 67 2-s2.0-79958818528 10.1093/cid/cir202
13. http://www.cdc.gov/hicpac/pdf/CAUTI/CAUTIguideline2009final.pdf
14. Garner J. S., Jarvis W. R., Emori T. G., Horan T. C., Hughes J. M., CDC Defionitions for nosocomial infections, 1988. The American Journal of Infection Control 1988 16 3 128 140 2-s2.0-0023821657
15. Falagas M. E., Koletsi P. K., Bliziotis I. A., The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. Journal of Medical Microbiology 2006 55 12 1619 1629 2-s2.0-33845390816 10.1099/jmm.0.46747-0 (Pubitemid 44902023)
16. Zarkotou O., Pournaras S., Tselioti P., Dragoumanos V., Pitiriga V., Ranellou K., Prekates A., Themeli-Digalaki K., Tsakris A., Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clinical Microbiology and Infection 2011 17 12 1798 1803 2-s2.0-81255171675 10.1111/j.1469-0691.2011.03514.x
17. Tsakris A., Kristo I., Poulou A., Themeli-Digalaki K., Ikonomidis A., Petropoulou D., Pournaras S., Sofianou D., Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory. Journal of Clinical Microbiology 2009 47 2 362 367 2-s2.0-60849103077 10.1128/JCM.01922-08
18. Franklin C., Liolios L., Peleg A. Y., Phenotypic detection of carbapenem-susceptible metallo- β -lactamase- producing gram-negative bacilli in the clinical laboratory. Journal of Clinical Microbiology 2006 44 9 3139 3144 2-s2.0-33748804967 10.1128/JCM.00879-06 (Pubitemid 44413743)
19. Tablan O. C., Anderson L. J., Besser R., Bridges C., Hajjeh R., Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR 2004 53 3 1 36 2-s2.0-1642525257
20. Patel G., Huprikar S., Factor S. H., Jenkins S. G., Calfee D. P., Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infection Control and Hospital Epidemiology 2008 29 12 1099 1106 2-s2.0-56749155916 10.1086/592412
21. Hussein K., Sprecher H., Mashiach T., Oren I., Kassis I., Finkelstein R., Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infection Control and Hospital Epidemiology 2009 30 7 666 671 2-s2.0-67651085441 10.1086/598244
22. Kritsotakis E. I., Tsioutis C., Roumbelaki M., Christidou A., Gikas A., Antibiotic use and the risk of carbapenem-resistant extended-spectrum- β -lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study. Journal of Antimicrobial Chemotherapy 2011 66 6 1383 1391 2-s2.0-79956058304 10.1093/jac/dkr116 dkr116
23. Daikos G. L., Vryonis E., Psichogiou M., Tzouvelekis L. S., Liatis S., Petrikkos P., Kosmidis C., Tassios P. T., Bamias G., Skoutelis A., Risk factors for bloodstream infection with Klebsiella pneumoniae producing VIM-1 metallo- β -lactamase. Journal of Antimicrobial Chemotherapy 2010 65 4 784 788 2-s2.0-77952567322 10.1093/jac/dkq005 dkq005
24. Falagas M. E., Rafailidis P. I., Kofteridis D., Virtzili S., Chelvatzoglou F. C., Papaioannou V., Maraki S., Samonis G., Michalopoulos A., Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case: control study. Journal of Antimicrobial Chemotherapy 2007 60 5 1124 1130 2-s2.0-35448951860 10.1093/jac/dkm356 (Pubitemid 47617764)
25. Mantzarlis K., Manoulakas S., Makris D., Zygoulis P., Zakynthinos E., K. Pneumoniae Producing Carbapenemases Infections in Critically Ill Patients: Prevalence and Risk Factors 2011 Berlin, Germany ESICM e-poster
26. Michalopoulos A., Falagas M., Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients. Annals of Intensive Care 2011 1 1, article 30 10.1186/2110-5820-1-30
27. Ziaka M., Markantonis S. L., Fousteri M., Zygoulis P., Panidis D., Karvouniaris M., Makris D., Zakynthinos E., Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection. Antimicrob Agents Chemother 2013 57 4 1938 1940
28. Polito A., Patorno E., Costello J. M., Salvin J. W., Emani S. M., Rajagopal S., Laussen P. C., Thiagarajan R. R., Perioperative factors associated with prolonged mechanical ventilation after complex congenital heart surgery. Pediatric Critical Care Medicine 2011 12 3 e122 e126 2-s2.0-79955921862 10.1097/PCC.0b013e3181e912bd
29. Gasink L. B., Edelstein P. H., Lautenbach E., Synnestvedt M., Fishman N. O., Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infection Control and Hospital Epidemiology 2009 30 12 1180 1185 2-s2.0-73449096797 10.1086/648451
30. Mouloudi E., Protonotariou E., Zagorianou A., Iosifidis E., Karapanagiotou A., Giasnetsova T., Tsioka A., Roilides E., Sofianou D., Gritsi-Gerogianni N., Bloodstream infections caused by metallo- β -lactamase/ Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Infection Control and Hospital Epidemiology 2010 31 12 1250 1256 2-s2.0-78649926918 10.1086/657135
31. Nseir S., Makris D., Mathieu D., Durocher A., Marquette C.-H., Intensive care unit-acquired infection as a side effect of sedation. Critical Care 2010 14, article R30 2-s2.0-77949447770 10.1186/cc8907
32. Borer A., Saidel-Odes L., Eskira S., Nativ R., Riesenberg K., Livshiz-Riven I., Schlaeffer F., Sherf M., Peled N., Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae. The American Journal of Infection Control 2012 40 421 425 2-s2.0-80052424081 10.1016/j.ajic.2011.05.022
33. Kwak Y. G., Choi S.-H., Choo E. J., Chung J.-W., Jeong J.-Y., Kim N. J., Woo J.-H., Ryu J., Kim Y. S., Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. Microbial Drug Resistance 2005 11 2 165 169 2-s2.0-18944362003 10.1089/mdr.2005.11.165 (Pubitemid 40705827)
34. Sánchez-Romero I., Asensio Á., Oteo J., Muñoz-Algarra M., Isidoro B., Vindel A., Álvarez-Avello J., Balandín-Moreno B., Cuevas O., Fernández-Romero S., Azañedo L., Sáez D., Campos J., Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome. Antimicrobial Agents and Chemotherapy 2012 56 1 420 427 2-s2.0-84455192532 10.1128/AAC.05036-11
35. Liu S.-W., Chang H.-J., Chia J.-H., Kuo A.-J., Wu T.-L., Lee M.-H., Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: a matched case-control study. Journal of Microbiology, Immunology and Infection 2012 45 2 113 119 2-s2.0-84859836779 10.1016/j.jmii.2011.09.026